Terms: = Ovarian cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Diagnosis
5 results:
1. Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.
Tedaldi G; Tebaldi M; Zampiga V; Danesi R; Arcangeli V; Ravegnani M; Cangini I; Pirini F; Petracci E; Rocca A; Falcini F; Amadori D; Calistri D
Oncotarget; 2017 Jul; 8(29):47064-47075. PubMed ID: 28423363
[TBL] [Abstract] [Full Text] [Related]
2. Malignant presentation of uterine lymphangioleiomyomatosis.
Szpurek D; Szubert S; Zielinski P; Frankowski A; Sajdak S; Moszynski R
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):603-7. PubMed ID: 26522119
[TBL] [Abstract] [Full Text] [Related]
3. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.
Tanwar PS; Mohapatra G; Chiang S; Engler DA; Zhang L; Kaneko-Tarui T; Ohguchi Y; Birrer MJ; Teixeira JM
Carcinogenesis; 2014 Mar; 35(3):546-53. PubMed ID: 24170201
[TBL] [Abstract] [Full Text] [Related]
4. Lymphangioleiomyomatosis suspected to be a gynecologic disease.
Yamashita S; Nakamura K; Shinozaki H; Minegishi T
J Obstet Gynaecol Res; 2011 Mar; 37(3):267-9. PubMed ID: 21314806
[TBL] [Abstract] [Full Text] [Related]
5. Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size.
Avila NA; Dwyer AJ; Murphy-Johnson DV; Brooks P; Moss J
AJR Am J Roentgenol; 2005 Feb; 184(2):459-64. PubMed ID: 15671364
[TBL] [Abstract] [Full Text] [Related]